Cargando…

Harnessing Antibody-Mimetic Selectivity for Activation-State-Specific Targeted Degradation of Endogenous K-Ras

Detalles Bibliográficos
Autor principal:	Ferguson, Fleur M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908021/ https://www.ncbi.nlm.nih.gov/pubmed/33655060 http://dx.doi.org/10.1021/acscentsci.1c00084

Ejemplares similares

Targeting Endogenous K-RAS for Degradation through the Affinity-Directed Protein Missile System
por: Röth, Sascha, et al.
Publicado: (2020)

Selective and noncovalent targeting of RAS mutants for inhibition and degradation
por: Teng, Kai Wen, et al.
Publicado: (2021)

Engineering subtilisin proteases that specifically degrade active RAS
por: Chen, Yingwei, et al.
Publicado: (2021)

Harnessing endogenous repair mechanisms for targeted gene knock-in of bovine embryos
por: Owen, Joseph R., et al.
Publicado: (2020)

Harnessing a Physiologic Mechanism for siRNA Delivery With Mimetic Lipoprotein Particles
por: Nakayama, Tomoko, et al.
Publicado: (2012)

Harnessing Endogenous Cellular Mechanisms for Bone Repair
por: Lo Sicco, Claudia, et al.
Publicado: (2017)

Harnessing Endogenous Stimuli for Responsive Materials in Theranostics
por: Cook, Alexander B., et al.
Publicado: (2021)

Potent and selective eradication of tumor cells by an EpCAM-targeted Ras-degrading enzyme
por: Palacio-Castañeda, Valentina, et al.
Publicado: (2023)

Mutant K-Ras in Pancreatic Cancer: An Insight on the Role of Wild-Type N-Ras and K-Ras-Dependent Cell Cycle Regulation
por: Ferguson, Robert, et al.
Publicado: (2023)

Advances in targeted degradation of endogenous proteins
por: Röth, Sascha, et al.
Publicado: (2019)

Long-acting antibody ligand mimetics for HER4-selective agonism
por: Shan, Lu, et al.
Publicado: (2020)

Harnessing the Anti-Cancer Natural Product Nimbolide for Targeted Protein Degradation
por: Spradlin, Jessica N., et al.
Publicado: (2019)

K-Ras protein as a drug target
por: McCormick, Frank
Publicado: (2016)

Absolute Quantification of Endogenous Ras Isoform Abundance
por: Mageean, Craig J., et al.
Publicado: (2015)

Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitors
por: Taraboletti, Giulia, et al.
Publicado: (2010)

Harnessing endogenous pathways and metabolites to treat or prevent neurodegenerative disease
por: Golde, Todd E, et al.
Publicado: (2013)

Mucosal absorption of therapeutic peptides by harnessing the endogenous sorting of glycosphingolipids
por: Garcia-Castillo, Maria Daniela, et al.
Publicado: (2018)

Harnessing the Benefits of Endogenous Hydrogen Sulfide to Reduce Cardiovascular Disease
por: Casin, Kevin M., et al.
Publicado: (2021)

The Masking Game: Design of Activatable Antibodies and Mimetics for Selective Therapeutics and Cell Control
por: Lucchi, Roberta, et al.
Publicado: (2021)

Direct targeting of oncogenic RAS mutants with a tumor-specific cytosol-penetrating antibody inhibits RAS mutant–driven tumor growth
por: Shin, Seung-Min, et al.
Publicado: (2020)

Protocol to select conformation-specific intracellular antibodies for targeted protein degradation in an engineered cell line
por: Bery, Nicolas, et al.
Publicado: (2020)

Current Approaches in NSCLC Targeting K-RAS and EGFR
por: Aran, Veronica, et al.
Publicado: (2019)

K-Ras prenylation as a potential anticancer target
por: Baranyi, Marcell, et al.
Publicado: (2020)

Degradation and Detection of Endocrine Disruptors by Laccase-Mimetic Polyoxometalates
por: Chen, Kun, et al.
Publicado: (2022)

Killer K-Ras
por: Powell, Kendall
Publicado: (2006)

K-RAS Is…Complicated
por: Clark, Geoffrey J.
Publicado: (2023)

Selective killing of K-ras–transformed pancreatic cancer cells by targeting NAD(P)H oxidase
por: Wang, Peng, et al.
Publicado: (2015)

Harnessing the Endogenous 2μ Plasmid of Saccharomyces cerevisiae for Pathway Construction
por: Yang, Jing, et al.
Publicado: (2021)

Abasic pivot substitution harnesses target specificity of RNA interference
por: Lee, Hye-Sook, et al.
Publicado: (2015)

Gene-specific quantification of nascent transcription following targeted degradation of endogenous proteins in cultured cells
por: Guarnaccia, Alissa D., et al.
Publicado: (2021)

Combination Therapy of the Active KRAS-Targeting Antibody inRas37 and a PI3K Inhibitor in Pancreatic Cancer
por: Lee, Ji Eun, et al.
Publicado: (2022)

Targeting K-Ras and apoptosis-driven cellular transformation in cancer
por: Godwin, Isha, et al.
Publicado: (2021)

Pathogen-driven degradation of endogenous and therapeutic antibodies during streptococcal infections
por: Toledo, Alejandro Gomez, et al.
Publicado: (2023)

Molecular targets of exercise mimetics and their natural activators
por: Jang, Young Jin, et al.
Publicado: (2021)

Interference with endogenous ras function inhibits cellular responses to wounding
Publicado: (1993)

Cytokines in Pain: Harnessing Endogenous Anti-Inflammatory Signaling for Improved Pain Management
por: Vanderwall, Arden G., et al.
Publicado: (2019)

Harnessing allogeneic CD4(+) T cells to reinvigorate host endogenous antitumor immunity
por: Mochizuki, Kazuhiro
Publicado: (2023)

GTP-State-Selective Cyclic Peptide Ligands of K-Ras(G12D) Block Its Interaction with Raf
por: Zhang, Ziyang, et al.
Publicado: (2020)

Synthetic mimetics of the endogenous gastrointestinal nanomineral: Silent constructs that trap macromolecules for intracellular delivery
por: Pele, Laetitia C., et al.
Publicado: (2017)

Harmine suppresses hyper-activated Ras–MAPK pathway by selectively targeting oncogenic mutated Ras/Raf in Caenorhabditis elegans
por: Ji, Jiaojiao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7t7a58f0go6m0opfvc0t7b36nm